Transient monocular visual loss after aurothioglucose.
D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006051:Aurothioglucose / Q000009:adverse effects*; D001766:Blindness / Q000139:chemically induced*; D006046:Gold / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged
D006051:Aurothioglucose; D006046:Gold